Lithium and brain signal transduction systems.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Biochemical Pharmacology

• Publication date

  1994-02-09

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-2952(94)90172-4PMID 8117309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of age and route of administration on LD50 of lithium chloride in the rat.

  2009cited by this paper
• Restoration of brainmyo-inositol levels in rats increases latency to lithium-pilocarpine seizures

  2005cited by this paper
• Lithium inhibition of protein kinase C activation-induced serotonin release

  2004cited by this paper
• Lithium Enhances Muscarinic Receptor–Stimulated CDP‐Diacylglycerol Formation in Inositol‐Depleted SK‐N‐SH Neuroblastoma Cells

  1993cited by this paper
• Measurement of Receptor‐Activated Phosphoinositide Turnover in Rat Brain: Nonequivalence of Inositol Phosphate and CDP‐Diacylglycerol Formation

  1993cited by this paper
• Elevated Phosphatidyl‐CMP Is Not the Source of Diacylglycerol Accumulation Induced by Lithium in NG108‐15 Cells

  1993cited by this paper
• CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia

  1993cited by this paper
• New Biochemical Hypotheses on the Mechanism of Action of Antidepressant Drugs: cAMP - Dependent Phosphorylation System

  1992cited by this paper
• Signal-transducing G proteins and antidepressant Drugs: Evidence for modulation of α subunit gene expression in rat brain

  1992cited by this paper
• Signal-transducing G proteins and antidepressant drugs: evidence for modulation of alpha subunit gene expression in rat brain.

  1992cited by this paper
• Phosphorylation of the spliced variant forms of the recombinant stimulatory guanine-nucleotide-binding regulatory protein (Gs alpha) by protein kinase C.

  1992cited by this paper
• Chronic lithium treatment prevents the dexamethasone-induced increase of brain polyamine metabolizing enzymes.

  1992cited by this paper
• Lithium Enhances Accumulation of [3H]Inositol Radioactivity and Mass of Second Messenger Inositol 1,4,5‐Trisphosphate in Monkey Cerebral Cortex Slices

  1992cited by this paper
• The role of microtubule‐associated protein 2 (MAP‐2) in neuronal growth, plasticity, and degeneration

  1992cited by this paper
• Effects of lithium on second messenger systems in the brain.

  1992cited by this paper
• Inositol triphosphate, cyclic AMP, and cyclic GMP in rat brain regions after lithium and seizures

  1992cited by this paper
• Acute lithium treatment enhances neuropeptide Y gene expression in rat hippocampus.

  1992cited by this paper
• The involvement of guanine nucleotide binding proteins in the pathogenesis and treatment of affective disorders

  1992cited by this paper
• G proteins: implications for psychiatry.

  1992cited by this paper
• Rhythms and the pharmacology of lithium.

  1992cited by this paper
• Lithium inhibits hepatic gluconeogenesis and phosphoenolpyruvate carboxykinase gene expression.

  1992cited by this paper
• Li+ increases accumulation of inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate in cholinergically stimulated brain cortex slices in guinea pig, mouse and rat. The increases require inositol supplementation in mouse and rat but not in guinea pig.

  1992cited by this paper
• Chronic Lithium Treatment Impairs Phosphatidylinositol Hydrolysis in Membranes from Rat Brain Regions

  1992cited by this paper
• Chronic lithium administration alters a prominent PKC substrate in rat hippocampus.

  1992cited by this paper
• Demonstration of inhibition of cyclic AMP accumulation in brain by very low concentrations of lithium in the presence of alpha-adrenoceptor blockade.

  1992cited by this paper
• The protein kinase C activators, phorbol 12-myristate,13-acetate and phorbol 12,13-dibutyrate, are convulsant in the pico-nanomolar range in mice.

  1992cited by this paper
• In Vivo Evidence that Lithium Inactivates Gi Modulation of Adenylate Cyclase in Brain

  1992cited by this paper
• Inhibitory effect of lithium on protein phosphorylation system associated to neuronal cytoskeleton

  1992cited by this paper
• Chronic Administration of Lithium or Other Antidepressants Increases Levels of DARPP‐32 in Rat Frontal Cortex

  1992cited by this paper
• Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: Model for its antimanic action

  1991cited by this paper
• Agonist control of G-protein levels.

  1991cited by this paper
• Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences.

  1991cited by this paper
• [3H]hemicholinium-3 binding in rats with status epilepticus induced by lithium chloride and pilocarpine.

  1991cited by this paper
• Lithium decreases Gs, Gi-1 and Gi-2 alpha-subunit mRNA levels in rat cortex.

  1991cited by this paper
• The Mechanisms of Action of Lithium: II. Effects on Adenylate Cyclase Activity and β-Adrenergic Receptor Binding in Normal Subjects

  1991cited by this paper
• Seizures increase acetylcholine and choline concentrations in rat brain regions

  1991cited by this paper
• Pertussis toxin potentiates seizures induced by pilocarpine, kainic acid and N-methyl-D-aspartate.

  1991cited by this paper
• Effects of chronic lithium treatment on protein kinase C and cyclic AMP-dependent protein phosphorylation.

  1991cited by this paper
• Evidence that a proconvulsant action of lithium is mediated by inhibition of myo-inositol phosphatase in mouse brain.

  1991cited by this paper
• Chronic lithium regulates the expression of adenylate cyclase and Gi-protein alpha subunit in rat cerebral cortex.

  1991cited by this paper
• Lithium augments pilocarpine-induced fos gene expression in rat brain.

  1991cited by this paper
• Analysis of the convulsant-potentiating effects of lithium in rats.

  1991cited by this paper
• Magnesium reversal of lithium inhibition of beta-adrenergic and muscarinic receptor coupling to G proteins.

  1991cited by this paper
• Lithium Chloride Inhibits the Phosphorylation of Newly Synthesized Neurofilament Protein, NF‐M, in Cultured Chick Sensory Neurons

  1991cited by this paper
• Brief chronic effects of lithium administration on rat brain phosphoinositides and phospholipids

  1991cited by this paper
• Okadaic acid identifies a phosphorylation/dephosphorylation cycle controlling the inhibitory guanine-nucleotide-binding regulatory protein Gi2.

  1991cited by this paper
• Chloroamphetamine did not prevent the effects of chronic antidepressants on 5-hydroxytryptamine inhibition of forskolin-stimulated adenylate cyclase in rat hippocampus.

  1991cited by this paper
• Differential effects of long-term lithium and carbamazepine administration on Gs alpha and Gi alpha protein in rat brain.

  1991cited by this paper
• Lithium effects on noradrenergic-linked adenylate cyclase activity in intact rat brain: an in vivo microdialysis study.

  1991cited by this paper
• Lithium-induced decrease of brain inositol and increase of brain inositol-1-phosphate is transient

  1991cited by this paper
• Influence of lithium on second messenger accumulation in NG108-15 cells.

  1991cited by this paper
• Effects of lithium and desimipramine on second messenger responses in rat hippocampus: relation to G protein effects.

  1991cited by this paper
• Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain.

  1991cited by this paper
• Differential effects of long-term lithium and carbamazepine administration on Gsα and Giα protein in rat brain

  1991cited by this paper
• Lithium decreases Gs, Gi-1 and Gi-2 α-subunit mRNA levels in rat cortex

  1991cited by this paper
• Lithium augments fos protoonocogene expression in PC12 pheochromocytoma cells: implications for therapeutic action of lithium.

  1990cited by this paper
• The effects of acute and chronic lithium treatment on pilocarpine‐stimulated phosphoinositide hydrolysis in mouse brain in vivo

  1990cited by this paper
• Changes in cerebral inositol-1-phosphate concentrations in LiCl-treated rats: Regional and strain differences

  1990cited by this paper
• Reduced inositol polyphosphate accumulation and inositol supply induced by lithium in stimulated cerebral cortex slices.

  1990cited by this paper
• Single and combined effects of desimipramine and lithium on serotonergic receptor number and second messenger function in rat brain.

  1990cited by this paper
• Lithium enhances neuronal muscarinic excitation by presynaptic facilitation.

  1990cited by this paper
• Evidence that Phosphoinositide Metabolism in Rat Cerebral Cortex Stimulated by Pilocarpine, Physostigmine, and Pargyline In Vivo Is Not Changed by Chronic Lithium Treatment

  1990cited by this paper
• Stimulation of hypothalamic opioid peptide release by lithium is mediated by opioid autoreceptors: evidence from a combined in vitro, ex vivo study.

  1990cited by this paper
• Role of phosphoinositides in transmembrane signaling.

  1990cited by this paper
• Lithium amplifies inhibitions of inositol phospholipid hydrolysis in mammalian brain slices

  1990cited by this paper
• Induction of c‐fos and TIS genes in cultured rat astrocytes by neurotransmitters

  1989cited by this paper
• Effects of lithium ex vivo on the GTP-mediated inhibition of calcium-stimulated adenylate cyclase activity in rat brain.

  1989cited by this paper
• Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats.

  1989cited by this paper
• Potentiation by lithium of CMP-phosphatidate formation in carbachol-stimulated rat cerebral-cortical slices and its reversal by myo-inositol.

  1989cited by this paper
• Lithium increases rat striatal beta- and gamma-preprotachykinin messenger RNAs.

  1989cited by this paper
• Long-term lithium treatment selectively reduces receptor-coupled inositol phospholipid hydrolysis in rat brain.

  1989cited by this paper
• Lithium Reduqes the Accumulation or Inositol Polyphosphate Second Messengers Following Cholinergic Stimulation of Cerebral Cortex Slices

  1989cited by this paper
• GTP-binding proteins as possible targets for protein kinase C action.

  1989cited by this paper
• Effects of Lithium on Inositol Phospholipid Hydrolysis and Inhibition of Dopamine D1 Receptor‐Mediated Cyclic AMP Formation by Carbachol in Rat Brain Slices

  1989cited by this paper
• Neural and developmental actions of lithium: a unifying hypothesis.

  1989cited by this paper
• Subacute and Chronic In Vivo Lithium Treatment Inhibits Agonist‐ and Sodium Fluoride‐Stimulated Inositol Phosphate Production in Rat Cortex

  1989cited by this paper
• Time-course of malaoxon-induced alterations in brain regional inositol-1-phosphate levels in convulsing and nonconvulsing rats

  1989cited by this paper
• Lithium reduces the accumulation of inositol polyphosphate second messengers following cholinergic stimulation of cerebral cortex slices.

  1989cited by this paper
• Chronically Administered Lithium Alters Neither myo‐Inositol Monophosphatase Activity nor Phosphoinositide Levels in Rat Brain

  1989cited by this paper
• Effects of GTP on hormone-stimulated adenylate cyclase activity in cerebral cortex, striatum, and hippocampus from rats treated chronically with lithium.

  1989cited by this paper
• Purification and properties of inositol-1,4-bisphosphatase from bovine brain.

  1988cited by this paper
• Lithium increases dynorphin A(1-8) and prodynorphin mRNA levels in the basal ganglia of rats.

  1988cited by this paper
• Lithium dramatically potentiates neurotensin/neuromedin N gene expression.

  1988cited by this paper
• Soman-induced convulsions affect the inositol lipid signaling system: potentiation by lithium; attenuation by atropine and diazepam.

  1988cited by this paper
• The purification and properties of myo-inositol monophosphatase from bovine brain.

  1988cited by this paper
• Change of synaptic membrane lipid composition and fluidity by chronic administration of lithium.

  1988cited by this paper
• Alteration of inositol phospholipid metabolism in rat cortex by lithium but not carbamazepine.

  1988cited by this paper
• Convulsions and cerebral inositol-1-phosphate levels in rats treated with diisopropyl fluorophosphate.

  1988cited by this paper
• Lithium stimulates the binding of GTP to the membranes of PC12 cells cultured with nerve growth factor.

  1988cited by this paper
• Purification and properties of myo-inositol-1-phosphatase from bovine brain.

  1988cited by this paper
• Lithium Selectively Inhibits Muscarinic Receptor‐Stimulated Inositol Tetrakisphosphate Accumulation in Mouse Cerebral Cortex Slices

  1988cited by this paper
• Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex

  1988cited by this paper
• Desensitization of Muscarinic Receptor‐Coupled Phosphoinositide Hydrolysis in Rat Hippocampus: Comparisons with the α1‐Adrenergic Response

  1988cited by this paper
• Acetylcholine Content in Rat Brain Is Elevated by Status Epilepticus Induced by Lithium and Pilocarpine

  1987cited by this paper
• Receptor Activation and Inositol Lipid Hydrolysis in Neural Tissues

  1987cited by this paper
• Status epilepticus is produced by administration of cholinergic agonists to lithium-treated rats: comparison with kainic acid.

  1987cited by this paper
• Evidence that inositol 1-phosphate in brain of lithium-treated rats results mainly from phosphatidylinositol metabolism.

  1987cited by this paper
• Chronic lithium treatment increases the phosphorylation of a 64-kDa protein in rat brains.

  1987cited by this paper
• Acute and chronic lithium treatments influence agonist and depolarization-stimulated inositol phospholipid hydrolysis in rat cerebral cortex.

  1987cited by this paper
• Lithium inhibits muscarinic-receptor-stimulated inositol tetrakisphosphate accumulation in rat cerebral cortex.

  1987cited by this paper

• Protein and mRNA expression of protein kinase C (PKC) in the postmortem brain of bipolar and schizophrenic subjects.

  2020cites this paper
• Nitric oxide involvement in additive antidepressant-like effect of agmatine and lithium in mice forced swim test.

  2018cites this paper
• Role of Protein Kinase C in Bipolar Disorder: A Review of the Current Literature

  2017cites this paper
• Lithium - therapeutic tool endowed with multiple beneficiary effects caused by multiple mechanisms.

  2016cites this paper
• The Role of Signal Transduction Systems in the Pathophysiology and Treatment of Bipolar Disorder

  2015cites this paper
• Characterization of lithium coordination sites with magic-angle spinning NMR.

  2015cites this paper
• Histological Changes in the Retina Provoked by Lithium Treatment in a Nocturnal Rodent (Lagostomus maximus maximus)

  2014cites this paper
• The Development of Neurodegeneration and Behavioural Alterations following Lithium/Pilocarpine-induced Status Epilepticus in Rats

  2013cites this paper
• Lithium’s Gene Expression Profile, Relevance to Neuroprotection A cDNA Microarray Study

  2013cites this paper
• Mecanismos implicados en la protección de la apoptosis neuronal en células granulares de cerebelo por litio y valproato

  2013cites this paper
• Lithium’s Gene Expression Profile, Relevance to Neuroprotection A cDNA Microarray Study

  2013cites this paper
• Determination of the lithium binding site in inositol monophosphatase, the putative target for lithium therapy, by magic-angle-spinning solid-state NMR.

  2012cites this paper
• Suizidprophylaktische Wirkung von Lithium

  2012cites this paper
• Chronic lithium impairs skin tolerance to ischemia in random-pattern skin flap of rats.

  2011cites this paper
• Additive anticonvulsant effects of agmatine and lithium chloride on pentylenetetrazole-induced clonic seizure in mice: involvement of α₂-adrenoceptor.

  2011cites this paper
• A Membrane Target of Lithium in Cortical Neurons, in vitro

  2011influential citation
• Lithium chloride disrupts consolidation of morphine-induced conditioned place preference in male mice: the nitric oxide/cyclic GMP signaling pathway.

  2011cites this paper
• The modulatory effect of lithium on doxorubicin-induced cardiotoxicity in rat.

  2010cites this paper
• Pharmacogenetics of lithium response in bipolar disorder.

  2010cites this paper
• Effect of lithium on secretory factors and growth stimulation by bombesin in rat pancreas and salivary glands.

  2010cites this paper
• Intracellular pathways underlying the effects of lithium

  2010cites this paper
• Regulation of α₂-adrenoceptor gene expression by chronic lithium treatment in rat brain.

  2010cites this paper
• Involvement of nitric oxide-cGMP pathway in the anticonvulsant effects of lithium chloride on PTZ-induced seizure in mice.

  2010cites this paper
• Genetic analysis of shudderer, the lithium-responsive neurological mutant of Drosophila melanogaster

  2010cites this paper
• Validating GSK3 as an in vivo target of lithium action.

  2009cites this paper
• Modulation of stress by imidazoline binding sites: Implications for psychiatric disorders

  2009cites this paper
• Inhibition by lithium of the nitrergic relaxation of rat anococcygeus muscle.

  2009cites this paper
• A role for nitrergic system in the antidepressant-like effects of chronic lithium treatment in the mouse forced swimming test.

  2009cites this paper
• Early effects of mood stabilizers on the Akt/GSK-3β signaling pathway and on cell survival and proliferation

  2009cites this paper
• Inositol depletion: a good or bad outcome of valproate treatment?

  2008cites this paper
• Quantitative Bestimmung des Nerve Growth Factor im Rattengehirn nach akuter und chronischer Behandlung mit Lithium und Carbamazepin

  2008cites this paper
• Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.

  2008cites this paper
• Lithium Induces Expression of HCNP and ChAT in the Septo-Hippocampal Cholinergic System of Rats

  2008cites this paper
• Characterization of the null murine sodium/myo-inositol cotransporter 1 (Smit1 or Slc5a3) phenotype: myo-inositol rescue is independent of expression of its cognate mitochondrial ribosomal protein subunit 6 (Mrps6) gene and of phosphatidylinositol levels in neonatal brain.

  2008cites this paper
• Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test.

  2008cites this paper
• Effect of lithium on the melatonin production in the pineal gland of viscacha

  2008cites this paper
• Nitric oxide involvement in the effect of acute lithium administration on the nonadrenergic noncholinergic-mediated relaxation of rat gastric fundus.

  2007cites this paper
• Flagellar Elongation and Gene Expression in Chlamydomonas reinhardtii

  2007cites this paper
• Lithium-methomyl induced seizures in rats: a new model of status epilepticus?

  2007cites this paper
• Role of Nitric Oxide and Prostaglandin Systems in Lithium Modulation of Acetylcholine Vasodilation

  2007cites this paper
• Effect of lithium on endothelium-dependent and neurogenic relaxation of rat corpus cavernosum: role of nitric oxide pathway.

  2007cites this paper
• Effect of chronic lithium administration on endothelium-dependent relaxation of rat mesenteric bed: role of nitric oxide.

  2007cites this paper
• Cell Membrane and Signal Transduction Pathways—Implications for the Pathophysiology of Bipolar Disorders

  2007cites this paper
• Astroglia growth retardation and increased microglia proliferation by lithium and ornithine decarboxylase inhibitor in rat cerebellar cultures: Cytotoxicity by combined lithium and polyamine inhibition

  2007cites this paper
• Capillary Ion Electrophoresis in Forensic Science

  2006cites this paper
• SMIT1 haploinsufficiency causes brain inositol deficiency without affecting lithium-sensitive behavior.

  2006cites this paper
• Inositol deficiency diet and lithium effects.

  2006cites this paper
• Intoxicación aguda por comprimidos de liberación sostenida de carbonato de litio. A propósito de un caso clínico

  2005cites this paper
• [Acute intoxication with sustained-release lithium carbonate tablets. A propos of a case].

  2005cites this paper
• Decrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeks.

  2005cites this paper
• Decrease in the AP-2 DNA-Binding Activity and in the Protein Expression of AP-2 a and AP-2 b in Frontal Cortex of Rats Treated with Lithium for 6 Weeks

  2005cites this paper
• Decrease in the AP-2 DNA-Binding Activity and in the Protein Expression of AP-2 α and AP-2 β in Frontal Cortex of Rats Treated with Lithium for 6 Weeks

  2005cites this paper
• Inositol has behavioral effects with adaptation after chronic administration

  2005cites this paper
• Response to lithium treatment in bipolar disorder as a pharmacogenetic phenotype

  2004cites this paper
• Role of intracellular calcium signaling in the pathophysiology and pharmacotherapy of bipolar disorder: current status

  2004cites this paper
• Valproate decreases inositol biosynthesis.

  2004cites this paper
• Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.

  2004cites this paper
• Combined chronic treatment with citalopram and lithium does not modify the regional neurochemistry of nitric oxide in rat brain.

  2004cites this paper
• COMBINED CHRONIC TREATMENT WITH CITALOPRAM AND

  2004cites this paper
• Chronic Lithium Treatment Attenuates Intracellular Calcium Mobilization

  2004cites this paper
• Lithium inhibits the modulatory effects of morphine on susceptibility to pentylenetetrazole-induced clonic seizure in mice: involvement of a nitric oxide pathway.

  2004cites this paper
• Pharmacogenetics and bipolar disorder

  2004cites this paper
• Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders.

  2003cites this paper
• Long-term responsiveness to lithium as a pharmacogenetic outcome variable: Treatment and etiologic implications

  2003cites this paper
• Possible role of 3′(2′)-phosphoadenosine-5′-phosphate phosphatase in the etiology and therapy of bipolar disorder

  2003cites this paper
• Lithium chloride, administered chronically to rats, does not affect the fractional phosphorylation of brain cytosolic phospholipase A2, while reducing its net protein level.

  2003cites this paper
• Predicting Response to Lithium in Mood Disorders

  2003cites this paper
• Shared effects of all three conventionalanti-bipolar drugs on the phosphoinositide system in astrocytes

  2003cites this paper
• Predicting response to lithium in mood disorders: role of genetic polymorphisms.

  2003cites this paper
• Molecular targets of lithium action.

  2003cites this paper
• Molecular targets of lithium action

  2003cites this paper
• Psychopharmakotherapie: pharmakologische Grundlagen

  2003cites this paper
• Overview of the Brain Polyamine-Stress-Response: Regulation, Development, and Modulation by Lithium and Role in Cell Survival

  2003cites this paper
• Mood stabilizers, glycogen synthase kinase-3β and cell survival

  2002cites this paper
• Long‐term lithium treatment prevents neurotoxic effects of β‐bungarotoxin in primary cultured neurons

  2002cites this paper
• Mood stabilizer psychopharmacology.

  2002cites this paper
• Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration.

  2002cites this paper
• Lithium Induces NF-κB Activation and Interleukin-8 Production in Human Intestinal Epithelial Cells*

  2002cites this paper
• Molecular Mechanisms of Action of Mood Stabilizers in Bipolar Disorder

  2002influential citation
• Phosphoinositide metabolism, lithium and manic depressive illness

  2002influential citation
• Seizure onset times for rats receiving systemic lithium and pilocarpine: sources of variability.

  2002cites this paper
• Mood stabilizers, glycogen synthase kinase-3beta and cell survival.

  2002cites this paper
• Dose-Response Effects of Lithium on Spatial Memory in the Black Molly Fish.

  2002cites this paper
• Myo-inositol-1-phosphate (MIP) synthase: a possible new target for antibipolar drugs.

  2002cites this paper
• Lithium long-term treatment in mood disorders: clinical and genetic predictors.

  2002cites this paper
• PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers

  2002cites this paper
• 79 MECHANISM OF ACTION OF ANTIDEPRESSANTS AND MOOD STABILIZERS

  2002cites this paper
• Expression of yeast INM1 encoding inositol monophosphatase is regulated by inositol, carbon source and growth stage and is decreased by lithium and valproate

  2002cites this paper
• The Wnt Signaling Pathway in Bipolar Disorder

  2002cites this paper
• Endophenotypes in bipolar disorder.

  2002cites this paper
• Signaling networks in the pathophysiology and treatment of mood disorders.

  2002cites this paper
• Lithium and valproic acid: parallels and contrasts in diverse signaling contexts.

  2002influential citation
• Pharmacogenetics in affective disorders.

  2002cites this paper
• The cholecystokinin analogues JMV‐180 and CCK‐8 stimulate phospholipase C through the same binding site of CCKA receptor in rat pancreatic acini

  2001cites this paper
• Mood stabilizers regulate cytoprotective and mRNA-binding proteins in the brain: long-term effects on cell survival and transcript stability.

  2001cites this paper
• Effects of subchronic lithium chloride treatment on G-protein subunits (Golf, Ggamma7) and adenylyl cyclase expressed specifically in the rat striatum.

  2001cites this paper
• Duygudurum Düzenleyici İki İlaç Lityum ve Valproat›n Etki Mekanizmalar›na İlişkin Bulgular

  2001cites this paper
• Identification of mood stabilizer-regulated genes by differential-display PCR.

  2001cites this paper
• Rapid cycling bipolar disease: New concepts and treatments

  2001cites this paper
• Emerging therapeutic targets in bipolar mood disorder

  2001cites this paper